Determinants of inhibitor development in previously treated hemophilia A patients

被引：0
|
作者：
Iorio, A. [1 ,2 ]
Barbara, A. [3 ]
Castaman, G. [4 ]
Fischer, K. [5 ]
Gilman, E. [6 ]
Goudemand, J. [7 ]
Kavakli, K. [8 ]
Kubicek-Hofmann, C. [9 ]
Lambert, T. [10 ]
Lissitchkov, T.
Makris, M. [6 ]
Matthew, P. [11 ]
Castelano, M. E. M.
Ozdemir, N.
Parra, R.
Peerlinck, K.
Rivolta, G. [12 ]
Romanov, V [13 ]
Roussel-Robert, V
Tagliaferri, A. [14 ]
Windyga, J. [15 ]
Zanon, E. [16 ]
机构：
[1] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada
[2] McMaster Univ, Med, Hamilton, ON, Canada
[3] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada
[4] Azienda Osped Policlin Careggi, Florence, Italy
[5] Van Creveld Clin, Utrecth, Netherlands
[6] Univ Sheffield, Sheffield, S Yorkshire, England
[7] Univ Lille, Lille, France
[8] Unviers Izmir, Izmir, Turkey
[9] Univ Berlin, Berlin, Germany
[10] Univ Paris, F-75252 Paris, France
[11] Bayer, Pittsburgh, PA USA
[12] Policlin Univ, Parma, Italy
[13] Baxter Healthcare, Los Angeles, CA USA
[14] Policlin Univ, Parma, Italy
[15] Univ Warsaw, Warsaw, Poland
[16] Univ Padua Polyclin, Padua, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR144
引用
下载
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [1] The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
    Kim, Ju Young
    You, Chur Woo
    BLOOD RESEARCH, 2019, 54 (03) : 204 - 209
  • [2] Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients
    Iorio, A.
    Barbara, A. M. G.
    Mathew, P.
    Rivolta, G. F.
    Romanov, V. V.
    Roussel-Robert, V.
    Tagliaferri, A.
    Windyga, J.
    HAEMOPHILIA, 2014, 20 : 38 - 38
  • [3] Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients
    Barbara, A. M. G.
    Aledort, L. M.
    Mathew, P.
    Mauser-Bunschoten, E.
    Rivolta, G. F.
    Romanov, V
    Tagliaferri, A.
    Roussel-Robert, V
    Windyga, J.
    Iorio, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 65 - 65
  • [4] Inhibitor development in previously treated patients with hemophilia A after switch to recombinant factor VIII
    Wu, Y.
    Tsay, W.
    Lin, H.
    Chang, C.
    Chen, M.
    Shen, M.
    HAEMOPHILIA, 2008, 14 : 52 - 53
  • [5] Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan
    Fukutake, Katsuyuki
    Taki, Masashi
    Matsushita, Tadashi
    Nogami, Keiji
    Shima, Midori
    Yoshioka, Akira
    Takamatsu, Junki
    Uchikawa, Haruhiko
    Takagi, Hiroshi
    Arai, Morio
    Engl, Werner
    Shirahata, Akira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (03) : 336 - 345
  • [6] Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan
    Katsuyuki Fukutake
    Masashi Taki
    Tadashi Matsushita
    Keiji Nogami
    Midori Shima
    Akira Yoshioka
    Junki Takamatsu
    Haruhiko Uchikawa
    Hiroshi Takagi
    Morio Arai
    Werner Engl
    Akira Shirahata
    International Journal of Hematology, 2019, 109 : 336 - 345
  • [7] Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts
    Marcucci, M.
    Fisher, K.
    Kenet, G.
    Young, G.
    Walker, I
    Thabane, L.
    Iorio, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 34 - 34
  • [8] Low inhibitor incidence in previously untreated hemophilia A patients (PUPs) treated with Octanate®
    Klukowska, A.
    Laguna, P.
    Komrska, V.
    Jansen, M.
    HAEMOPHILIA, 2010, 16 : 37 - 37
  • [9] Absence of inhibitor development in previously treated patients and a low inhibitor incidence in previously untreated haemophilia A patients treated with Octanate®
    Jansen, M.
    Klukowska, A.
    Laguna, P.
    HAEMOPHILIA, 2008, 14 : 45 - 45
  • [10] Inhibitor development in previously untreated patients (PUP's) with hemophilia A treated with Kogenate(R): (GIPSI - German Italian PUP study on inhibitor development)
    Ettingshausen, CE
    Gringeri, A
    Budde, U
    Mannucci, PM
    Kreuz, W
    Lusher, J
    BLOOD, 1997, 90 (10) : 687 - 687
12345